EODData

MEMBERSHIP LEVELS REGISTRATION LOG IN

GERN

08 Aug 25 16:37
LAST:

1.280

CHANGE:
 0.02		OPEN:
1.290		HIGH:
1.330		ASK:
2.250		VOLUME:
11.3M
CHG(%):
1.54		PREV:
1.300		LOW:
1.260		BID:
2.000		OPEN INT:
0

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolumeOpen Interest
08 Aug 251.2901.3301.2601.28011.32M0
07 Aug 251.4201.4301.2901.30014.19M0
06 Aug 251.3001.3901.2801.39028.42M0
05 Aug 251.2201.2401.1901.2008.56M0
04 Aug 251.1701.2301.1601.21013.97M0
01 Aug 251.1301.1801.1101.1709.86M0
31 Jul 251.1101.1601.0901.15012.79M0
30 Jul 251.1301.1601.0901.1008.83M0
29 Jul 251.1701.1701.1301.13510.28M0
28 Jul 251.2701.2801.1301.15022.67M0

COMPANY PROFILE

NASDAQ, GERN - Geron Corp

Geron is developing first-in-class biopharmaceuticals for the treatment of  cancer and chronic degenerative diseases, including spinal cord injury, heart  failure and diabetes. We are advancing telomerase targeted therapies, including  an anti-cancer drug and a cancer vaccine, through multiple clinical trials. We  are also the world leader in the development of human embryonic stem cell-based  therapeutics, with our spinal cord injury treatment anticipated to be the first  such product to enter clinical development.  We were incorporated in 1990 under the laws of Delaware. Our principal  executive offices are located at 230 Constitution Drive, Menlo Park, California  94025. Our telephone number is (650) 473-7700.  ...

FUNDAMENTALS

Sector:Consumer Durables
Industry:Major Pharmaceuticals
P/E Ratio:N/A
PEG Ratio:N/A
EPS:N/A
DivYield:N/A
PtB:3.3967
PtS:54.93
EBITDA:N/A
Shares:636.92M
Market Cap:815.26M
52wk range:1.09 - 4.84

SYMBOL HISTORY

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

MEMBER LOGIN

Login
   Add to Watchlist
216.73.216.229
United States

GLOBAL INDICES

CodeLastChange
COMP21,4502071.0
DJI44,17600.0
SP5006,38900.0
DAX24,16300.0
FTSE7,488-50.1
NI22521,848120.1
CAC405,354410.8
GLD1,78300.0
BDI1,200494.3
HSI24,85900.0